Biomind Labs Inc. (BMNDF)
OTCMKTS · Delayed Price · Currency is USD
0.0110
0.00 (0.00%)
Mar 25, 2026, 9:30 AM EST
Biomind Labs Market Cap
Biomind Labs has a market cap or net worth of $853.29 thousand as of March 26, 2026.
Market Cap
853.29K
Enterprise Value
1.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since July 27, 2021, Biomind Labs's market cap has decreased from 18.69M to 853.29K, a decrease of -95.43%. That is a compound annual growth rate of -48.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 853.29K | -90.35% |
| Dec 30, 2025 | 8.84M | -67.68% |
| Dec 19, 2022 | 27.36M | 46.40% |
| Jul 27, 2021 | 18.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halberd | 1.12M |
| International Stem Cell | 1.08M |
| Eastgate Biotech | 1.06M |
| Emmaus Life Sciences | 1.05M |
| Avenue Therapeutics | 955.44K |
| Lyra Therapeutics | 870.23K |
| Eloxx Pharmaceuticals | 811.51K |
| Scorpius Holdings | 794.86K |